June 17, 2025
FDA grants fast-track status to SolasCure’s gel for calciphylaxis ulcers
The US Food and Drug Administration (FDA) has granted fast track designation to SolasCure's investigational Aurase Wound Gel (AWG) for treating calciphylaxis ulcers.